Topic

Somatuline Depot (lanreotide)

A collection of 8 issues

How to Get Somatuline Depot (Lanreotide) Covered by Aetna CVS Health in Illinois: Complete Prior Authorization Guide

Answer Box: Getting Somatuline Depot Covered by Aetna CVS Health in Illinois Fastest path to approval: Submit Aetna's prior authorization form with complete clinical documentation showing medical necessity for acromegaly or neuroendocrine tumors. No octreotide trial required. First step today: Download the Illinois-specific PA form from PrescriberPoint and

How to Get Somatuline Depot (Lanreotide) Covered by Cigna in Ohio: Complete Prior Authorization and Appeals Guide

Answer Box: Getting Somatuline Depot Covered by Cigna in Ohio Cigna requires prior authorization for Somatuline Depot (lanreotide), typically places it on Tier 4/5 specialty formulary, and mandates step therapy with octreotide (Sandostatin LAR) first. In Ohio, if denied, you have 180 days to appeal internally, then 180 days

How to Get Somatuline Depot (Lanreotide) Covered by Humana in New Jersey: Complete Guide with Forms and Appeal Steps

Answer Box: Getting Somatuline Depot Covered by Humana in New Jersey Yes, Humana covers Somatuline Depot (lanreotide) in New Jersey with prior authorization for acromegaly, GEP-NETs, and carcinoid syndrome. Most approvals require documentation of diagnosis by an endocrinologist or oncologist, plus evidence of octreotide trial (or medical contraindication). If denied,

How to Get Somatuline Depot (Lanreotide) Covered by Humana in Texas: Complete Prior Authorization and Appeals Guide

Quick Answer: Getting Somatuline Depot Covered by Humana in Texas Eligibility: Humana Medicare Advantage requires prior authorization for Somatuline Depot (lanreotide) for acromegaly, GEP-NETs, and carcinoid syndrome. Fastest path: Have your endocrinologist or oncologist submit PA with documented octreotide trial failure/intolerance, complete diagnostic workup (IGF-1, chromogranin A, or 5-HIAA)

How to Get Somatuline Depot (Lanreotide) Covered by Humana in Pennsylvania: Complete Prior Authorization and Appeals Guide

Answer Box: Getting Somatuline Depot Covered by Humana in Pennsylvania Fastest path to approval: Submit prior authorization with medical necessity documentation through your endocrinologist or oncologist. If denied, you have 65 days to appeal internally, then 4 months for Pennsylvania's external review program (50% overturn rate in 2024)

How to Get Somatuline Depot (Lanreotide) Covered by Aetna CVS Health in Virginia: Complete Prior Authorization Guide

Answer Box: Getting Somatuline Depot Covered by Aetna CVS Health in Virginia Eligibility: Aetna CVS Health covers Somatuline Depot (lanreotide) for FDA-approved indications (acromegaly, GEP-NETs, carcinoid syndrome) with prior authorization and typically requires step therapy with octreotide first. Fastest Path: 1) Gather octreotide trial documentation or contraindication evidence, 2) Submit

Getting Somatuline Depot (Lanreotide) Covered by Cigna in Texas: Prior Authorization, Appeals, and Cost-Saving Strategies

Quick Answer: Cigna requires prior authorization for Somatuline Depot (lanreotide) with documentation of octreotide trial unless contraindicated. Your endocrinologist/oncologist must submit medical necessity forms within 72 hours for standard review. If denied, file internal appeal within 180 days, then external review through Texas IRO within 4 months. Commercial patients

How to Get Somatuline Depot (Lanreotide) Covered by Humana in Illinois: Complete Guide to Prior Authorization, Appeals, and Forms

Answer Box: Quick Start Guide Somatuline Depot (lanreotide) requires prior authorization from Humana in Illinois. Your fastest path to approval: 1) Verify your diagnosis meets Humana's criteria (acromegaly, GEP-NETs, or carcinoid syndrome), 2) Submit the prior authorization request through Humana's provider portal or fax to 1-888-447-3430,